Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Bladder Cancer

  Free Subscription


06.08.2018

3 Anticancer Res
1 Biochem Biophys Res Commun
1 Biosci Rep
1 BJU Int
1 BMJ Case Rep
1 Cancer Commun (Lond)
1 Carcinogenesis
1 Ceylon Med J
1 Clin Genitourin Cancer
1 Eur J Oncol Nurs
1 Eur Urol Focus
1 Genes Environ
1 Hinyokika Kiyo
1 Histopathology
2 Int Braz J Urol
1 Int J Oncol
1 J Clin Neurosci
1 J Environ Pathol Toxicol Oncol
1 J Pediatr Surg
1 J Vis Exp
1 Med Sci Monit
3 Medicine (Baltimore)
1 Mol Med Rep
1 Onco Targets Ther
1 Oncol Lett
1 Toxicol Sci
2 Transl Androl Urol
1 Urol Oncol
1 World J Urol


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Anticancer Res

  1. NAKAMURA R, Kakuhara H, Kikuchi K, Segawa T, et al
    Partial Bladder Boost Using Lipiodol Marking During Image-guided Radiotherapy for Bladder Cancer.
    Anticancer Res. 2018;38:4827-4831.
    PubMed     Text format     Abstract available

  2. TSAI KW, Kuo WT, Jeng SY
    Tight Junction Protein 1 Dysfunction Contributes to Cell Motility in Bladder Cancer.
    Anticancer Res. 2018;38:4607-4615.
    PubMed     Text format     Abstract available

  3. GOUSSIA AC, Papoudou-Bai A, Charchanti A, Kitsoulis P, et al
    Alterations of p53 and Rb Pathways Are Associated with High Proliferation in Bladder Urothelial Carcinomas.
    Anticancer Res. 2018;38:3985-3988.
    PubMed     Text format     Abstract available


    Biochem Biophys Res Commun

  4. LI Z, Hong S, Liu Z
    LncRNA LINC00641 predicts prognosis and inhibits bladder cancer progression through miR-197-3p/KLF10/PTEN/PI3K/AKT cascade.
    Biochem Biophys Res Commun. 2018 Jul 27. pii: S0006-291X(18)31622.
    PubMed     Text format     Abstract available


    Biosci Rep

  5. QIN Z, Wang Y, Tang J, Zhang L, et al
    High LINC01605 expression predicts poor prognosis and promotes tumor progression via upregulation of MMP9 in bladder cancer.
    Biosci Rep. 2018 Jul 27. pii: BSR20180562. doi: 10.1042/BSR20180562.
    PubMed     Text format     Abstract available


    BJU Int

  6. HEIJNSDIJK EAM, Nieboer D, Garg T, Lansdorp-Vogelaar I, et al
    Cost-effectiveness of surveillance schedules in older adults with non-muscle-invasive bladder cancer.
    BJU Int. 2018 Aug 1. doi: 10.1111/bju.14502.
    PubMed     Text format     Abstract available


    BMJ Case Rep

  7. GUPTE A, Matcha A, Lauzardo M
    Mycobacterium bovis BCG spinal osteomyelitis in a patient with bladder cancer without a history of BCG instillation.
    BMJ Case Rep. 2018;2018.
    PubMed     Text format     Abstract available


    Cancer Commun (Lond)

  8. HUANG Y, Zhou S, He C, Deng J, et al
    Phenformin alone or combined with gefitinib inhibits bladder cancer via AMPK and EGFR pathways.
    Cancer Commun (Lond). 2018;38:50.
    PubMed     Text format     Abstract available


    Carcinogenesis

  9. ALLIONE A, Pardini B, Viberti C, Giribaldi G, et al
    MMP23B expression and protein levels in blood and urine are associated with bladder cancer.
    Carcinogenesis. 2018 Jul 20. pii: 5056806. doi: 10.1093.
    PubMed     Text format     Abstract available


    Ceylon Med J

  10. JAYARAJAH U, Herath KB, Fernando MH, Kuruppu SN, et al
    A clinico-pathological study of non-urothelial bladder cancers in a cohort of patients from a tertiary care urology unit in Sri Lanka
    Ceylon Med J. 2018;63:92-94.
    PubMed     Text format    


    Clin Genitourin Cancer

  11. KIMURA S, Soria F, D'Andrea D, Foerster B, et al
    Prognostic Value of Serum Cholinesterase in Non-muscle-invasive Bladder Cancer.
    Clin Genitourin Cancer. 2018 Jul 6. pii: S1558-7673(18)30415.
    PubMed     Text format     Abstract available


    Eur J Oncol Nurs

  12. PATERSON C, Jensen BT, Jensen JB, Nabi G, et al
    Unmet informational and supportive care needs of patients with muscle invasive bladder cancer: A systematic review of the evidence.
    Eur J Oncol Nurs. 2018;35:92-101.
    PubMed     Text format     Abstract available


    Eur Urol Focus

  13. BABJUK M, Burger M, Comperat EM, Gontero P, et al
    Indication for a Single Postoperative Instillation of Chemotherapy in Non-muscle-invasive Bladder Cancer: What Factors Should Be Considered?
    Eur Urol Focus. 2018 Jul 27. pii: S2405-4569(18)30189.
    PubMed     Text format     Abstract available


    Genes Environ

  14. EL-ARABEY AA
    Correction to: New insight for metformin against bladder cancer.
    Genes Environ. 2018;40:16.
    PubMed     Text format     Abstract available


    Hinyokika Kiyo

  15. KIDA K, Shimizu Y, Ogawa K, Kanamaru S, et al
    [Distant Metastasis in Patients with Non-Muscle Invasive Bladder Cancer without Local Recurrence : Report of Two Rare Cases].
    Hinyokika Kiyo. 2018;64:271-275.
    PubMed     Text format     Abstract available


    Histopathology

  16. PATRIARCA C, Hurle R, Colombo P, Colecchia M, et al
    In reply to: Lawless et al. Stalk versus base invasion in pT1 papillary cancers of the bladder: improved substaging system predicting the risk of progression.
    Histopathology. 2018;72:361-362.
    PubMed     Text format    


    Int Braz J Urol

  17. BOLAT D, Gunlusoy B, Aydogdu O, Aydin ME, et al
    Comparing the short - term outcomes and complications of monopolar and bipolar transurethral resection of bladder tumors in patients with coronary artery disese: a prospective, randomized, controlled study.
    Int Braz J Urol. 2018;44:717-725.
    PubMed     Text format     Abstract available

  18. GARRIDO-ABAD P, Rodriguez-Cabello MA, Gonzalez-Gordaliza C, Vera-Beron R, et al
    BCG instillations can mimic prostate cancer on multiparametric MRI.
    Int Braz J Urol. 2018;44:835-837.
    PubMed     Text format    


    Int J Oncol

  19. CHEN X, Xu Z, Zhu Z, Chen A, et al
    Modulation of G6PD affects bladder cancer via ROS accumulation and the AKT pathway in vitro.
    Int J Oncol. 2018 Jul 25. doi: 10.3892/ijo.2018.4501.
    PubMed     Text format     Abstract available


    J Clin Neurosci

  20. SAADEH YS, Hollon TC, Fisher-Hubbard A, Savastano LE, et al
    Primary diffuse leptomeningeal melanomatosis: Description and recommendations.
    J Clin Neurosci. 2018;50:139-143.
    PubMed     Text format     Abstract available


    J Environ Pathol Toxicol Oncol

  21. BAYRAM D, Armagan I, Ozgocmen M, Senol N, et al
    Determination of Apoptotic Effect of Juglone on Human Bladder Cancer TCC-SUP and RT-4 Cells: An In Vitro Study.
    J Environ Pathol Toxicol Oncol. 2018;37:173-181.
    PubMed     Text format     Abstract available


    J Pediatr Surg

  22. SALTSMAN JA, Malek MM, Reuter VE, Hammond WJ, et al
    Urothelial neoplasms in pediatric and young adult patients: A large single-center series.
    J Pediatr Surg. 2018;53:306-309.
    PubMed     Text format     Abstract available


    J Vis Exp

  23. YU C, Stefanson O, Liu Y, Wang ZA, et al
    Novel Method of Plasmid DNA Delivery to Mouse Bladder Urothelium by Electroporation.
    J Vis Exp. 2018;.
    PubMed     Text format     Abstract available


    Med Sci Monit

  24. HUANG Y, Li G, Wang K, Mu Z, et al
    Collagen Type VI Alpha 3 Chain Promotes Epithelial-Mesenchymal Transition in Bladder Cancer Cells via Transforming Growth Factor beta (TGF-beta)/Smad Pathway.
    Med Sci Monit. 2018;24:5346-5354.
    PubMed     Text format     Abstract available


    Medicine (Baltimore)

  25. DARRIET F, Bernioles P, Loukil A, Saidani N, et al
    Fluorescence in situ hybridization microscopic detection of Bacilli Calmette Guerin mycobacteria in aortic lesions: A case report.
    Medicine (Baltimore). 2018;97:e11321.
    PubMed     Text format     Abstract available

  26. STIGLIANO A, Lardo P, Cerquetti L, Aschelter AM, et al
    Treatment responses to antiangiogenetic therapy and chemotherapy in nonsecreting paraganglioma (PGL4) of urinary bladder with SDHB mutation: A case report.
    Medicine (Baltimore). 2018;97:e10904.
    PubMed     Text format     Abstract available

  27. NIU Q, Lu Y, Wu Y, Xu S, et al
    The effect of marital status on the survival of patients with bladder urothelial carcinoma: A SEER database analysis.
    Medicine (Baltimore). 2018;97:e11378.
    PubMed     Text format     Abstract available


    Mol Med Rep

  28. ZHU YD, Lu MY
    Increased expression of TNFRSF14 indicates good prognosis and inhibits bladder cancer proliferation by promoting apoptosis.
    Mol Med Rep. 2018 Jul 23. doi: 10.3892/mmr.2018.9306.
    PubMed     Text format     Abstract available


    Onco Targets Ther

  29. BAYRAMOV B, Gunes S, Buyukalpelli R, Aydin O, et al
    Promoter methylation analysis of CDH1 and p14ARF genes in patients with urothelial bladder cancer.
    Onco Targets Ther. 2018;11:4189-4196.
    PubMed     Text format     Abstract available


    Oncol Lett

  30. STAKISAITIS D, Jukneviciene M, Ulys A, Zaliuniene D, et al
    ABO blood group polymorphism has an impact on prostate, kidney and bladder cancer in association with longevity.
    Oncol Lett. 2018;16:1321-1331.
    PubMed     Text format     Abstract available


    Toxicol Sci

  31. LIN YC, Chen WJ, Huang CY, Shiue HS, et al
    Corrigendum to "Polymorphisms of Arsenic (+3 Oxidation State) Methyltransferase and Arsenic Methylation Capacity Affect the Risk of Bladder Cancer".
    Toxicol Sci. 2018;164:644.
    PubMed     Text format    


    Transl Androl Urol

  32. SHERIF A
    The long perspective in emergence of neoadjuvant chemotherapy for bladder cancer in Ontario, Canada-space for improvement with regular and organized multidisciplinary team meetings.
    Transl Androl Urol. 2018;7:508-510.
    PubMed     Text format    

  33. KOSHKIN VS, Grivas P
    Perioperative chemotherapy for muscle-invasive bladder cancer: the importance of multidisciplinary management for evidence-based practice and transformative research.
    Transl Androl Urol. 2018;7:504-507.
    PubMed     Text format    


    Urol Oncol

  34. BOSSCHIETER J, Nieuwenhuijzen JA, Vis AN, van Ginkel T, et al
    An immediate, single intravesical instillation of mitomycin C is of benefit in patients with non-muscle-invasive bladder cancer irrespective of prognostic risk groups.
    Urol Oncol. 2018 Jul 28. pii: S1078-1439(18)30195.
    PubMed     Text format     Abstract available


    World J Urol

  35. ZATTONI F, Morlacco A, Zattoni F
    Preoperative chronic kidney disease before radical cystectomy as predictor of oncological outcomes: a pick of the iceberg?
    World J Urol. 2018;36:993.
    PubMed     Text format    


Thank you for your interest in scientific medicine.


AMEDEO Bladder Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: